GI Alliance-Richmond

Richmond, Virginia 23229

3 studies enrolling now · 3 studies all time

What they study most

Crohn Disease (CD), Moderately to Severely Active Crohns Disease, Ulcerative Colitis, Ulcerative Colitis (UC)

Studies at this site

• LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis: — Recruiting now
• A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease — Recruiting now
• INSIGHT-IBD Pragmatic Study — Starting soon